Karyopharm Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $295.0M
Liabilities Breakdown FY2019
Total Liabilities: $245.2M
Asset Breakdown
Total Assets: $295.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $128.9M | 43.7% |
| Accounts Receivable | $7.9M | 2.7% |
| Inventory | $346.0K | 0.1% |
| Property, Plant & Equipment | $3.0M | 1.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $154.9M | 52.5% |
Liabilities Breakdown
Total Liabilities: $245.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $985.0K | 0.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $244.2M | 99.6% |